Jupiter Neurosciences, Common Stock Performance
| JUNS Stock | USD 9.73 1.13 10.41% |
Jupiter Neurosciences, holds a performance score of 24 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.35, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Jupiter Neurosciences, are expected to decrease by larger amounts. On the other hand, during market turmoil, Jupiter Neurosciences, is expected to outperform it. Use Jupiter Neurosciences, Common total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to analyze future returns on Jupiter Neurosciences, Common.
Risk-Adjusted Performance
24 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Jupiter Neurosciences, Common are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Jupiter Neurosciences, unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (10.41) | Five Day Return (19.79) | Year To Date Return 77.23 | Ten Year Return 143.25 | All Time Return 143.25 |
1 | Jupiter Neurosciences, Inc. Announces Closing of 11 million Initial Public Offering - GlobeNewswire | 12/04/2024 |
2 | Opening Day Jinxin Technology, zSpace make public debut - MSN | 12/09/2024 |
3 | Jupiter Neurosciences inks deal for Southeast Asia expansion | 12/20/2024 |
| Begin Period Cash Flow | 64.4 K |
Jupiter |
Jupiter Neurosciences, Relative Risk vs. Return Landscape
If you would invest 549.00 in Jupiter Neurosciences, Common on September 24, 2024 and sell it today you would earn a total of 424.00 from holding Jupiter Neurosciences, Common or generate 77.23% return on investment over 90 days. Jupiter Neurosciences, Common is currently generating 4.9933% in daily expected returns and assumes 15.7976% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Jupiter, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Jupiter Neurosciences, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jupiter Neurosciences,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jupiter Neurosciences, Common, and traders can use it to determine the average amount a Jupiter Neurosciences,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3161
| Best Portfolio | Best Equity | JUNS | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.8 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.99 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.32 actual daily | 24 76% of assets perform better |
Based on monthly moving average Jupiter Neurosciences, is performing at about 24% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jupiter Neurosciences, by adding it to a well-diversified portfolio.
Jupiter Neurosciences, Fundamentals Growth
Jupiter Stock prices reflect investors' perceptions of the future prospects and financial health of Jupiter Neurosciences,, and Jupiter Neurosciences, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jupiter Stock performance.
| Current Valuation | 202.55 M | ||||
| EBITDA | (4.56 M) | ||||
| Net Income | (4.78 M) | ||||
| Total Debt | 2.25 M | ||||
| Cash Flow From Operations | (480.95 K) | ||||
| Market Capitalization | 200.22 M | ||||
| Total Asset | 148.59 K | ||||
| Retained Earnings | (23.58 M) | ||||
About Jupiter Neurosciences, Performance
Assessing Jupiter Neurosciences,'s fundamental ratios provides investors with valuable insights into Jupiter Neurosciences,'s financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Jupiter Neurosciences, is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (32.19) | (33.80) | |
| Return On Capital Employed | 0.69 | 0.46 | |
| Return On Assets | (32.19) | (33.80) | |
| Return On Equity | 0.82 | 0.54 |
Things to note about Jupiter Neurosciences, performance evaluation
Checking the ongoing alerts about Jupiter Neurosciences, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jupiter Neurosciences, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jupiter Neurosciences, is way too risky over 90 days horizon | |
| Jupiter Neurosciences, appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (4.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Jupiter Neurosciences, generates negative cash flow from operations | |
| Jupiter Neurosciences, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Jupiter Neurosciences inks deal for Southeast Asia expansion |
- Analyzing Jupiter Neurosciences,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jupiter Neurosciences,'s stock is overvalued or undervalued compared to its peers.
- Examining Jupiter Neurosciences,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jupiter Neurosciences,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jupiter Neurosciences,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jupiter Neurosciences,'s stock. These opinions can provide insight into Jupiter Neurosciences,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.